Pacific Point Advisors LLC Purchases 1,187 Shares of UnitedHealth Group Incorporated $UNH

Pacific Point Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 30.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,145 shares of the healthcare conglomerate’s stock after purchasing an additional 1,187 shares during the quarter. UnitedHealth Group comprises about 0.9% of Pacific Point Advisors LLC’s portfolio, making the stock its 27th biggest position. Pacific Point Advisors LLC’s holdings in UnitedHealth Group were worth $1,605,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Financial Management Professionals Inc. boosted its holdings in UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after purchasing an additional 17 shares during the last quarter. Retirement Planning Group LLC boosted its stake in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after buying an additional 21 shares during the last quarter. Net Worth Advisory Group lifted its holdings in UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after acquiring an additional 21 shares during the period. Bensler LLC grew its stake in shares of UnitedHealth Group by 0.3% during the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after purchasing an additional 22 shares during the period. Finally, Buska Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% in the 1st quarter. Buska Wealth Management LLC now owns 1,494 shares of the healthcare conglomerate’s stock worth $782,000 after purchasing an additional 23 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $345.11 on Wednesday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $312.56 billion, a price-to-earnings ratio of 14.95, a P/E/G ratio of 2.25 and a beta of 0.45. The firm has a fifty day moving average price of $303.65 and a 200 day moving average price of $357.64. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the company earned $6.80 EPS. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

A number of brokerages have commented on UNH. Sanford C. Bernstein upped their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Morgan Stanley raised their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Finally, Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.